Unsymmetrical cyanine dimer compounds and their application
View Patent ↗Embodiments of the present invention provide methods and nucleic acid reporter molecules for the detection of nucleic acid in a sample. The nucleic acid reporter molecule comprises two unsymmetrical cyanine monomer moieties, which may be the same or different, that are covalently attached by a linker comprising at least one aromatic, heteroaromatic, cyclic or heterocyclic moiety comprising 3-20 non-hydrogen atoms selected from the group consisting of O, N, S, P and C. The linker may be rigid, relatively flexible or some degree thereof. The unsymmetrical cyanine monomer moieties comprise a substituted or unsubstituted benzazolium moiety and a substituted or unsubstituted pyridinium or quinolinium moiety that is connected by a methine bridge that is monomethine, trimethine or pentamethine. The linkers form the cyanine dimer compounds by attaching to the pyridinium or quinolinium moiety of the monomer moieties. The present nucleic acid reporter molecules find utility in forming a nucleic acid-reporter molecule complex and detecting the nucleic acid. In particular, present nucleic acid reporter molecules with a rigid linker and monomer moieties with a monomethine bridge find utility in detecting RNA in the presence of DNA.
1. A nucleic acid reporter molecule that has a RNA/DNA ratio of fluorescence enhancement greater than about one wherein the nucleic acid reporter molecule comprises a first monomethine unsymmetrical cyanine monomer moiety, a second monomethine unsymmetrical cyanine monomer moiety and a linker that is
wherein R 8 is a substituted heteroatom or an unsubstituted heteroatom; R 9 is a substituted heteroatom or an unsubstituted heteroatom; R 12 is a substituted heteroatom or an unsubstituted heteroatom; each Z is —(CH 2 ) g wherein g is 0 or 1; and the first unsymmetrical cyanine monomer moiety is covalently attached to the linker; and the second unsymmetrical cyanine monomer moiety is covalently attached to the linker.
2. The reporter molecule according to claim 1 , wherein
R 8 is —NR 2 , —N═ or S wherein R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support;
R 9 is —NR 2 , —N═ or S wherein R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support; and,
R 12 is —NR 2 , —N═ or S wherein R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support.
3. The reporter molecule according to claim 1 , wherein the monomethine unsymmetrical cyanine monomer moiety has the general formula:
wherein R 3 is independently hydrogen, unsubstituted C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, unsubstituted fused benzene, substituted fused benzene, unsubstituted trifluoromethyl, substituted trifluoromethyl, unsubstituted halogen, substituted halogen, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support or substituted solid support;
R 4 is independently a unsubstituted C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support or substituted solid support;
X is O, S, or CR 6 R 7 wherein each R 6 and R 7 are independently a unsubstituted C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, substituted solid support or R 6 and R 7 taken together form a 5- or 6-membered saturated ring; and,
K is substituted pyridinium, unsubstituted pyridinium, substituted quinolinium, or unsubstituted quinolinium wherein the first unsymmetrical cyanine monomer moiety is covalently attached to the linker at the K moiety; and the second unsymmetrical cyanine monomer moiety is covalently attached to the linker at the K moiety.
4. The reporter molecule according to claim 3 , wherein the reactive group, solid support and carrier molecule comprise a linker that is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-20 nonhydrogen atoms selected from the group consisting of C, N, P, O and S; and are composed of any combination of ether, thioether, amine, ester, carboxamide, sulfonamide, hydrazide bonds and aromatic or heteroaromatic bonds.
5. The reporter molecule according to claim 4 , wherein the reactive group is selected from the group consisting of an acrylamide, an activated ester of a carboxylic acid, a carboxylic ester, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an anhydride, an aniline, an amine, an aryl halide, an azide, an aziridine, a boronate, a diazoalkane, a haloacetamide, a haloalkyl, a halotriazine, a hydrazine, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a silyl halide, a sulfonyl halide, a thiol and a photoactivatable group.
6. The reporter molecule according to claim 5 , wherein the reactive group is selected from the group consisting of carboxylic acid, succinimidyl ester of a carboxylic acid, hydrazide, amine and a maleimide.
7. The reporter molecule according to claim 4 , wherein the carrier molecule is selected from the group consisting of an amino acid, a peptide, a protein, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid polymer, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a synthetic polymer, a polymeric microparticle, a biological cell or a virus.
8. The reporter molecule according to claim 7 , wherein the carrier molecule is selected from the group consisting of an antibody or fragment thereof, an avidin or streptavidin, a biotin, a blood component protein, a dextran, an enzyme, an enzyme inhibitor, a hormone, an IgG binding protein, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a microorganism, a metal binding protein, a metal chelating moiety, a non-biological microparticle, a peptide toxin, a phosphotidylserine-binding protein, a structural protein, a small-molecule drug, or a tyramide.
9. The reporter molecule according to claim 4 , wherein the solid support is selected from the group consisting of a microfluidic chip, a silicon chip, a microscope slide, a microplate well, silica gels, polymeric membranes, particles, derivatized plastic films, glass beads, cotton, plastic beads, alumina gels, polysaccharides, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, magnetic bead, paramagnetic bead, and superparamagnetic bead.
10. The reporter molecule according to claim 9 , wherein the solid support is selected from the group consisting of Sepharose, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, FICOLL, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose and starch.
11. The reporter molecule according to claim 3 , wherein the linker is
12. The reporter molecule according to claim 11 , wherein the reporter molecule is
13. The reporter molecule according to claim 3 , wherein R 9 is N or S and R 12 is N or S.
14. The reporter molecule according to claim 3 , wherein the linker is
15. The reporter molecule according to claim 14 , wherein the reporter molecule
16. The reporter molecule according to claim 3 , wherein the linker is
17. The reporter molecule according to claim 16 , wherein said reporter molecule
18. The reporter molecule according to claim 3 , wherein the linker is
19. The reporter molecule according to claim 18 , wherein the compound is
20. A nucleic acid reporter molecule that is
21. A kit for detecting nucleic acid in a sample, wherein the kit comprises: a nucleic acid reporter molecule comprising a first nucleic acid complexing monomer moiety, a second nucleic acid complexing monomer moiety and a linker that comprises at least one aromatic, heteroaromatic, cyclic or heterocyclic moiety comprising 3-20 non-hydrogen atoms selected from the group consisting of O, N, S, P and C, wherein the first nucleic acid complexing monomer moiety and the second nucleic acid complexing monomer moiety are covalently attached to the linker, and wherein the nucleic acid reporter molecule is
22. The kit according to claim 21 , wherein the kit further comprises instructions for detecting the nucleic acid.
23. The kit according to claim 21 , wherein the kit further comprises instruction for detecting intracellular RNA.
24. The kit according to claim 21 , wherein the kit further comprises at least one component that is a sample preparation reagent, a buffer agent, an organic solvent or an addition nucleic acid reporter molecule.
25. A kit for detecting nucleic acid in a sample, wherein the kit comprises: a nucleic acid reporter molecule
wherein the molecule is
26. The kit according to claim 25 , wherein the sample comprises biological fluids, buffer solutions, live cells, fixed cells, eukaryotic cells, prokaryotic cells, nucleic acid polymers, nucleotides, a polymeric gel or tissue sections.
27. The kit according to claim 26 , wherein the nucleic acid is single stranded RNA, double stranded RNA, single stranded DNA or double stranded DNA.
28. A kit for detecting nucleic acid in a sample, wherein the kit comprises: a nucleic acid reporter molecule that is according to the formula
wherein each R 3 is independently hydrogen, unsubstituted C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, unsubstituted fused benzene, substituted fused benzene, unsubstituted trifluoromethyl, substituted trifluoromethyl, unsubstituted halogen, substituted halogen, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support or substituted solid support;
each R 4 is independently a unsubstituted C 1 -C 6 alkyl substituted C 1 -C 6 alkyl unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support or substituted solid support;
X is O, S or CR 6 R 7 wherein each R 6 and R 7 are independently a unsubstituted C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl unsubstituted reactive group substituted reactive group unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, substituted solid support or R 6 and R 7 taken together form a 5- or 6-membered saturated ring;
j is 0, 1, or 2;
linker is a series of stable covalent bonds comprising 1-30 nonhydrogen atoms selected from the group consisting of C, N, O, S and P; and,
K is substituted pyridinium, unsubstituted pyridinium, substituted quinolinium, or unsubstituted quinolinium;
wherein the linker comprises at least one aromatic, heteroaromatic, cyclic or heterocyclic moiety comprising 3-20 non-hydrogen atoms selected from the group consisting of O, N, S, P and C.
29. The kit according to claim 28 , wherein the linker has the formula (I) —(Y) r —(CH 2 ) m -T q -(CH 2 ) n -E-(CH 2 ) n -T q -(CH 2 ) m —(Y) r —;
wherein Y is a linear or branched moiety comprising 1-20 non-hydrogen atoms selected from the group consisting of C, N, O, P and S;
T is a unsubstituted heteroatom or a substituted heteroatom;
E is an aromatic, heteroaromatic, cyclic or heterocyclic moiety comprising 3-20 non-hydrogen atoms selected from the group consisting of O, N, S, P and C;
r is independently 0 or 1;
m is an integer of 0-6;
n is independently 0 or 1;
q is independently 0 or 1;
and wherein the first unsymmetrical cyanine monomer moiety is covalently attached to the linker; and the second unsymmetrical cyanine monomer moiety is covalently attached to the linker.
30. The kit according to claim 29 , wherein E is
wherein R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support.
31. The kit according to claim 29 , wherein T, when present, is —NR 2 , —N═ or S wherein the R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support.
32. The kit according to claim 30 , wherein the linker is
each R 8 , R 9 , R 10 , R 11 and R 12 are independently a —NR 2 , —N═ or S wherein R 2 is hydrogen, amine, substituted amine, substituted C 1 -C 6 alkyl, unsubstituted C 1 -C 6 alkyl, unsubstituted reactive group, substituted reactive group, unsubstituted carrier molecule, substituted carrier molecule, unsubstituted solid support, or substituted solid support; each Z is independently —(CH 2 ) g — wherein g is 0 or 1, wherein the dashed line is attached directly to the K moiety of the unsymmetrical cyanine monomer.
33. The kit according to claim 32 , wherein R 8 is S.
34. The kit according to claim 32 , wherein R 12 is —NH or —N═.
35. The kit according to claim 34 , wherein the linker is